| 1 | Identification and targeting of regulators of SARS-CoV-2–host interactions in the airway epithelium | 8.1 | 1 | Citations (PDF) |
| 2 | Phase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine | 8.1 | 4 | Citations (PDF) |
| 3 | Identification of amino acid residues in polymerase PB2 responsible for differential replication and pathogenicity of avian influenza virus H5N1 isolated from human and cattle in Texas, US | 3.9 | 14 | Citations (PDF) |
| 4 | Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activation | 5.2 | 2 | Citations (PDF) |
| 5 | BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza | 5.2 | 3 | Citations (PDF) |
| 6 | An mRNA-based broad-spectrum antiviral inspired by ISG15 deficiency protects against viral infections in vitro and in vivo | 8.7 | 8 | Citations (PDF) |
| 7 | Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity | 3.1 | 5 | Citations (PDF) |
| 8 | SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells | 6.8 | 11 | Citations (PDF) |
| 9 | ACE2 and TMPRSS2 distribution in the respiratory tract of different animal species and its correlation with SARS-CoV-2 tissue tropism | 2.3 | 11 | Citations (PDF) |
| 10 | Visualization of Early RNA Replication Kinetics of SARS-CoV-2 by Using Single Molecule RNA-FISH Combined with Immunofluorescence | 2.2 | 7 | Citations (PDF) |
| 11 | SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract | 2.4 | 16 | Citations (PDF) |
| 12 | Plitidepsin as an Immunomodulator against Respiratory Viral Infections | 0.8 | 7 | Citations (PDF) |
| 13 | Monkeypox virus genomic accordion strategies | 10.8 | 56 | Citations (PDF) |
| 14 | Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis | 5.2 | 21 | Citations (PDF) |
| 15 | Evolution of STAT2 resistance to flavivirus NS5 occurred multiple times despite genetic constraints | 10.8 | 15 | Citations (PDF) |
| 16 | Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer | 1.9 | 1 | Citations (PDF) |
| 17 | MHC class II proteins mediate sialic acid independent entry of human and avian H2N2 influenza A viruses | 9.9 | 27 | Citations (PDF) |
| 18 | Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants | 2.7 | 8 | Citations (PDF) |
| 19 | Sarbecovirus programmed ribosome frameshift RNA element folding studied by NMR spectroscopy and comparative analyses | 10.7 | 5 | Citations (PDF) |
| 20 | Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity | 3.9 | 11 | Citations (PDF) |
| 21 | Comparative Analysis of 2022 Outbreak MPXV and Previous Clade II MPXV | 2.0 | 16 | Citations (PDF) |
| 22 | Avian influenza A (H5N1) virus in dairy cattle: origin, evolution, and cross-species transmission | 3.1 | 149 | Citations (PDF) |
| 23 | Recombination across distant coronavirid species and genera is a rare event with distinct genomic features | 2.4 | 2 | Citations (PDF) |
| 24 | TRIM65 regulates innate immune signaling by enhancing K6-linked ubiquitination of IRF3 and its chromatin recruitment | 4.4 | 10 | Citations (PDF) |
| 25 | Portable UV-C device to treat high flow of infectious aerosols generated during clinical respiratory care | 2.7 | 3 | Citations (PDF) |
| 26 | Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity | 2.4 | 9 | Citations (PDF) |
| 27 | Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs | 3.9 | 9 | Citations (PDF) |
| 28 | An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination | 8.7 | 22 | Citations (PDF) |
| 29 | Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection | 14.1 | 44 | Citations (PDF) |
| 30 | A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity | 0.8 | 19 | Citations (PDF) |
| 31 | Vaccine-induced immune thrombotic thrombocytopenia: what do we know hitherto? | 1.6 | 21 | Citations (PDF) |
| 32 | Group 1 and group 2 hemagglutinin stalk antibody response according to age | 3.3 | 12 | Citations (PDF) |
| 33 | Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice | 3.9 | 18 | Citations (PDF) |
| 34 | Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico | 3.9 | 46 | Citations (PDF) |
| 35 | Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals | 2.9 | 13 | Citations (PDF) |
| 36 | Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets | 10.8 | 64 | Citations (PDF) |
| 37 | Annual (2023) taxonomic update of RNA-directed RNA polymerase-encoding negative-sense RNA viruses (realm Riboviria: kingdom Orthornavirae: phylum Negarnaviricota) | 1.9 | 74 | Citations (PDF) |
| 38 | Engineering Non-Human RNA Viruses for Cancer Therapy | 1.9 | 8 | Citations (PDF) |
| 39 | Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19 | 14.1 | 79 | Citations (PDF) |
| 40 | SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice | 2.4 | 80 | Citations (PDF) |
| 41 | Functional Effects of Cardiomyocyte Injury in COVID-19 | 2.4 | 20 | Citations (PDF) |
| 42 | Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer | 3.9 | 96 | Citations (PDF) |
| 43 | Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation | 1.5 | 41 | Citations (PDF) |
| 44 | Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19 | 1.9 | 47 | Citations (PDF) |
| 45 | ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2 | 2.4 | 48 | Citations (PDF) |
| 46 | Obesity and Metabolic Dysregulation in Children Provide Protective Influenza Vaccine Responses | 2.2 | 13 | Citations (PDF) |
| 47 | SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters | 30.6 | 656 | Citations (PDF) |
| 48 | Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission | 12.2 | 188 | Citations (PDF) |
| 49 | Advances and gaps in SARS-CoV-2 infection models | 2.9 | 81 | Citations (PDF) |
| 50 | Profiling Selective Packaging of Host RNA and Viral RNA Modification in SARS-CoV-2 Viral Preparations | 2.8 | 11 | Citations (PDF) |
| 51 | Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production | 1.6 | 4 | Citations (PDF) |
| 52 | Susceptibility of sheep to experimental co-infection with the ancestral lineage of SARS-CoV-2 and its alpha variant | 3.9 | 30 | Citations (PDF) |
| 53 | Human SUMOylation Pathway Is Critical for Influenza B Virus | 2.2 | 2 | Citations (PDF) |
| 54 | Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models | 1.0 | 28 | Citations (PDF) |
| 55 | Broadly neutralizing antibodies target a haemagglutinin anchor epitope | 30.6 | 192 | Citations (PDF) |
| 56 | The RNA helicase DHX16 recognizes specific viral RNA to trigger RIG-I-dependent innate antiviral immunity | 4.4 | 35 | Citations (PDF) |
| 57 | Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial | 6.6 | 53 | Citations (PDF) |
| 58 | Limited extent and consequences of pancreatic SARS-CoV-2 infection | 4.4 | 54 | Citations (PDF) |
| 59 | Right Ventricular Abnormality in Patients Hospitalized With COVID-19 Infection During Omicron Variant Surge | 1.5 | 4 | Citations (PDF) |
| 60 | Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer | 28.4 | 17 | Citations (PDF) |
| 61 | Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial | 9.2 | 33 | Citations (PDF) |
| 62 | Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam | 2.0 | 41 | Citations (PDF) |
| 63 | Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine | 2.3 | 7 | Citations (PDF) |
| 64 | Type I and Type II Interferon Antagonism Strategies Used by Paramyxoviridae: Previous and New Discoveries, in Comparison | 2.2 | 16 | Citations (PDF) |
| 65 | Avian Paramyxovirus 4 Antitumor Activity Leads to Complete Remissions and Long-term Protective Memory in Preclinical Melanoma and Colon Carcinoma Models | 2.1 | 6 | Citations (PDF) |
| 66 | Nuclear speckle integrity and function require TAO2 kinase | 5.2 | 15 | Citations (PDF) |
| 67 | Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice | 2.3 | 28 | Citations (PDF) |
| 68 | Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples | 0.8 | 3 | Citations (PDF) |
| 69 | Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity | 2.7 | 23 | Citations (PDF) |
| 70 | Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA | 8.6 | 46 | Citations (PDF) |
| 71 | Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera | 10.8 | 40 | Citations (PDF) |
| 72 | Proteomic Identification of Potential Target Proteins of Cathepsin W for Its Development as a Drug Target for Influenza | 2.3 | 14 | Citations (PDF) |
| 73 | eIF5A is activated by virus infection or dsRNA and facilitates virus replication through modulation of interferon production | 2.8 | 14 | Citations (PDF) |
| 74 | Autoantibodies against type I IFNs in patients with critical influenza pneumonia | 5.9 | 122 | Citations (PDF) |
| 75 | Common and species-specific molecular signatures, networks, and regulators of influenza virus infection in mice, ferrets, and humans | 8.1 | 10 | Citations (PDF) |
| 76 | Mucosal delivery of RNA vaccines by Newcastle disease virus vectors | 3.8 | 6 | Citations (PDF) |
| 77 | Immunodominance hierarchy after seasonal influenza vaccination | 3.9 | 15 | Citations (PDF) |
| 78 | SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules | 3.3 | 3 | Citations (PDF) |
| 79 | Interaction between chicken TRIM25 and MDA5 and their role in mediated antiviral activity against IBDV infection | 2.9 | 13 | Citations (PDF) |
| 80 | Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity | 10.8 | 72 | Citations (PDF) |
| 81 | Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | 3.9 | 15 | Citations (PDF) |
| 82 | An intranasal recombinant NDV-BRSV Fopt vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection | 2.7 | 1 | Citations (PDF) |
| 83 | Induction and Evasion of Type-I Interferon Responses during Influenza A Virus Infection | 2.9 | 27 | Citations (PDF) |
| 84 | Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model | 1.9 | 20 | Citations (PDF) |
| 85 | A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners | 3.9 | 85 | Citations (PDF) |
| 86 | MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells | 4.4 | 380 | Citations (PDF) |
| 87 | Zika virus NS3 protease induces bone morphogenetic protein-dependent brain calcification in human fetuses | 9.9 | 34 | Citations (PDF) |
| 88 | Experimental re-infected cats do not transmit SARS-CoV-2 | 3.9 | 50 | Citations (PDF) |
| 89 | Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A | 26.1 | 329 | Citations (PDF) |
| 90 | Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression | 8.1 | 207 | Citations (PDF) |
| 91 | TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming | 14.1 | 45 | Citations (PDF) |
| 92 | COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms | 2.6 | 85 | Citations (PDF) |
| 93 | Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine** | 11.6 | 64 | Citations (PDF) |
| 94 | Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes | 2.2 | 20 | Citations (PDF) |
| 95 | IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization | 5.9 | 21 | Citations (PDF) |
| 96 | Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model | 3.1 | 86 | Citations (PDF) |
| 97 | Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience | 3.8 | 222 | Citations (PDF) |
| 98 | TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammationCell, 2021, 184, 2618-2632.e17 | 23.4 | 123 | Citations (PDF) |
| 99 | Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics | 3.1 | 19 | Citations (PDF) |
| 100 | Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture | 4.4 | 69 | Citations (PDF) |
| 101 | Immunological imprinting of the antibody response in COVID-19 patients | 10.8 | 211 | Citations (PDF) |
| 102 | Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms | 0.9 | 153 | Citations (PDF) |
| 103 | Influenza Virus Infects and Depletes Activated Adaptive Immune Responders | 7.7 | 13 | Citations (PDF) |
| 104 | An Interview with Adolfo Garcia-Sastre, PhD | 1.0 | 0 | Citations (PDF) |
| 105 | Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses | 1.0 | 11 | Citations (PDF) |
| 106 | Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19 | 2.7 | 46 | Citations (PDF) |
| 107 | Functional landscape of SARS-CoV-2 cellular restriction | 8.6 | 219 | Citations (PDF) |
| 108 | Development of a Macrophage-Based ADCC Assay | 1.9 | 10 | Citations (PDF) |
| 109 | Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 | 26.1 | 210 | Citations (PDF) |
| 110 | Aryl Sulfonamide Inhibits Entry and Replication of Diverse Influenza Viruses via the Hemagglutinin Protein | 4.0 | 18 | Citations (PDF) |
| 111 | Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype | 3.1 | 12 | Citations (PDF) |
| 112 | Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice | 2.4 | 135 | Citations (PDF) |
| 113 | Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity | 5.3 | 112 | Citations (PDF) |
| 114 | African Swine Fever Virus Induces STAT1 and STAT2 Degradation to Counteract IFN-I Signaling | 2.9 | 34 | Citations (PDF) |
| 115 | Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression | 1.7 | 36 | Citations (PDF) |
| 116 | Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagy | 9.9 | 49 | Citations (PDF) |
| 117 | Virus-induced senescence is a driver and therapeutic target in COVID-19 | 30.6 | 327 | Citations (PDF) |
| 118 | Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs | 3.1 | 48 | Citations (PDF) |
| 119 | Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice | 3.3 | 20 | Citations (PDF) |
| 120 | A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses | 10.8 | 107 | Citations (PDF) |
| 121 | Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device | 2.7 | 17 | Citations (PDF) |
| 122 | COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models | 10.8 | 52 | Citations (PDF) |
| 123 | Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 | 10.8 | 303 | Citations (PDF) |
| 124 | Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1 | 2.7 | 17 | Citations (PDF) |
| 125 | Evolution of influenza A virus in intensive and free-range swine farms in Spain | 2.2 | 20 | Citations (PDF) |
| 126 | Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats | 3.3 | 29 | Citations (PDF) |
| 127 | Evolution of enhanced innate immune evasion by SARS-CoV-2 | 30.6 | 381 | Citations (PDF) |
| 128 | Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial | 9.2 | 135 | Citations (PDF) |
| 129 | A novel SUMOylation site in the influenza a virus NS1 protein identified with a highly sensitive FRET assay | 2.8 | 11 | Citations (PDF) |
| 130 | Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing | 30.6 | 791 | Citations (PDF) |
| 131 | Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection | 3.9 | 195 | Citations (PDF) |
| 132 | SARS-CoV-2 infection, disease and transmission in domestic cats | 3.9 | 257 | Citations (PDF) |
| 133 | Animal models for COVID-19 | 30.6 | 859 | Citations (PDF) |
| 134 | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms | 26.1 | 700 | Citations (PDF) |
| 135 | Current Status of COVID‐19 (Pre)Clinical Vaccine Development | 0.9 | 5 | Citations (PDF) |
| 136 | Current Status of COVID‐19 (Pre)Clinical Vaccine Development | 11.6 | 69 | Citations (PDF) |
| 137 | Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies | 1.9 | 11 | Citations (PDF) |
| 138 | Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate | 6.6 | 115 | Citations (PDF) |
| 139 | Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer | 26.5 | 418 | Citations (PDF) |
| 140 | Structural basis for STAT2 suppression by flavivirus NS5 | 5.8 | 73 | Citations (PDF) |
| 141 | SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling | 5.2 | 548 | Citations (PDF) |
| 142 | Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses | 16.6 | 100 | Citations (PDF) |
| 143 | Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 | 26.1 | 2,079 | Citations (PDF) |
| 144 | Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs | 9.9 | 90 | Citations (PDF) |
| 145 | A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine | 1.9 | 80 | Citations (PDF) |
| 146 | A serological assay to detect SARS-CoV-2 seroconversion in humans | 22.6 | 1,855 | Citations (PDF) |
| 147 | A Genome-Wide CRISPR-Cas9 Screen Reveals the Requirement of Host Cell Sulfation for Schmallenberg Virus Infection | 2.4 | 28 | Citations (PDF) |
| 148 | Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion | 3.3 | 32 | Citations (PDF) |
| 149 | Hybrid Gene Origination Creates Human-Virus Chimeric Proteins during InfectionCell, 2020, 181, 1502-1517.e23 | 23.4 | 45 | Citations (PDF) |
| 150 | Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses | 3.3 | 21 | Citations (PDF) |
| 151 | Gut microbiota manipulation during the prepubertal period shapes behavioral abnormalities in a mouse neurodevelopmental disorder model | 2.7 | 36 | Citations (PDF) |
| 152 | Varying Inoculum Dose to Assess the Roles of the Immune Response and Target Cell Depletion by the Pathogen in Control of Acute Viral Infections | 1.5 | 12 | Citations (PDF) |
| 153 | The Global Phosphorylation Landscape of SARS-CoV-2 InfectionCell, 2020, 182, 685-712.e19 | 23.4 | 1,065 | Citations (PDF) |
| 154 | Coronavirus disease 2019 (COVID-19) hospitalized patients with acute kidney injury treated with acute peritoneal dialysis do not have infectious peritoneal dialysis effluent | 4.2 | 16 | Citations (PDF) |
| 155 | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing | 30.6 | 4,340 | Citations (PDF) |
| 156 | Live Visualization of Hemagglutinin Dynamics during Infection by Using a Novel Reporter Influenza A Virus | 2.2 | 3 | Citations (PDF) |
| 157 | STAT2 Limits Host Species Specificity of Human Metapneumovirus | 2.2 | 5 | Citations (PDF) |
| 158 | Influenza virus NS1- C/EBPβ gene regulatory complex inhibits RIG-I transcription | 2.7 | 11 | Citations (PDF) |
| 159 | Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells | 2.4 | 10 | Citations (PDF) |
| 160 | Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay | 2.0 | 31 | Citations (PDF) |
| 161 | OTUB1 Is a Key Regulator of RIG-I-Dependent Immune Signaling and Is Targeted for Proteasomal Degradation by Influenza A NS1 | 4.4 | 70 | Citations (PDF) |
| 162 | Host immune response–inspired development of the influenza vaccine | 0.9 | 16 | Citations (PDF) |
| 163 | Passenger Mutations Confound Phenotypes of SARM1-Deficient Mice | 4.4 | 54 | Citations (PDF) |
| 164 | Characterizing Emerging Canine H3 Influenza Viruses | 2.9 | 46 | Citations (PDF) |
| 165 | Chemical intervention of influenza virus mRNA nuclear export | 2.9 | 19 | Citations (PDF) |
| 166 | A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial | 22.6 | 353 | Citations (PDF) |
| 167 | Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection | 10.8 | 100 | Citations (PDF) |
| 168 | Molecular basis for the exploitation of nuclear mRNA export by influenza A virus | 2.3 | 0 | Citations (PDF) |
| 169 | Moving from Empirical to Rational Vaccine Design in the ‘Omics’ Era | 1.9 | 28 | Citations (PDF) |
| 170 | Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1 | 2.4 | 95 | Citations (PDF) |
| 171 | Protection against influenza infection requires early recognition by inflammatory dendritic cells through C-type lectin receptor SIGN-R1 | 9.9 | 39 | Citations (PDF) |
| 172 | Characterization of swine-origin H1N1 canine influenza viruses | 3.9 | 23 | Citations (PDF) |
| 173 | Structural basis for influenza virus NS1 protein block of mRNA nuclear export | 9.9 | 77 | Citations (PDF) |
| 174 | The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response | 2.9 | 88 | Citations (PDF) |
| 175 | Snatch-and-Grab Inhibitors to Fight the Flu | 23.4 | 1 | Citations (PDF) |
| 176 | Bat influenza viruses transmit among bats but are poorly adapted to non-bat species | 9.9 | 69 | Citations (PDF) |
| 177 | TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection | 1.9 | 9 | Citations (PDF) |
| 178 | Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy | 16.6 | 98 | Citations (PDF) |
| 179 | A HER2-Displaying Virus-Like Particle Vaccine Protects from Challenge with Mammary Carcinoma Cells in a Mouse Model | 1.9 | 16 | Citations (PDF) |
| 180 | Severe influenza pneumonitis in children with inherited TLR3 deficiency | 5.9 | 190 | Citations (PDF) |
| 181 | N-Glycolylneuraminic Acid as a Receptor for Influenza A Viruses | 4.4 | 107 | Citations (PDF) |
| 182 | A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer InterfaceCell, 2019, 177, 1136-1152.e18 | 23.4 | 263 | Citations (PDF) |
| 183 | Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism | 2.4 | 31 | Citations (PDF) |
| 184 | Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein | 2.4 | 20 | Citations (PDF) |
| 185 | Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model | 3.3 | 55 | Citations (PDF) |
| 186 | MHC class II proteins mediate cross-species entry of bat influenza viruses | 30.6 | 152 | Citations (PDF) |
| 187 | Viral Fitness Landscapes in Diverse Host Species Reveal Multiple Evolutionary Lines for the NS1 Gene of Influenza A Viruses | 4.4 | 21 | Citations (PDF) |
| 188 | Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins in vitro and in vivo | 2.9 | 40 | Citations (PDF) |
| 189 | Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1 | 2.4 | 15 | Citations (PDF) |
| 190 | Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts | 3.9 | 26 | Citations (PDF) |
| 191 | Virus‐induced autophagic degradation of
STAT
2 as a mechanism for interferon signaling blockade | 3.5 | 39 | Citations (PDF) |
| 192 | Packaging of the Influenza Virus Genome Is Governed by a Plastic Network of RNA- and Nucleoprotein-Mediated Interactions | 2.4 | 40 | Citations (PDF) |
| 193 | Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice | 2.4 | 80 | Citations (PDF) |
| 194 | Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors | 4.0 | 36 | Citations (PDF) |
| 195 | Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation | 2.0 | 8 | Citations (PDF) |
| 196 | SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses | 2.7 | 18 | Citations (PDF) |
| 197 | Zika Virus Alters DNA Methylation of Neural Genes in an Organoid Model of the Developing Human Brain | 2.8 | 68 | Citations (PDF) |
| 198 | Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein | 2.7 | 28 | Citations (PDF) |
| 199 | Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling | 2.4 | 79 | Citations (PDF) |
| 200 | Specific Mutations in the PB2 Protein of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of Bat Influenza A-Like Viruses | 2.4 | 14 | Citations (PDF) |
| 201 | Spatial-Temporal Lineage Restrictions of Embryonic p63+ Progenitors Establish Distinct Stem Cell Pools in Adult Airways | 5.3 | 203 | Citations (PDF) |
| 202 | Is It Possible to Develop a “Universal” Influenza Virus Vaccine? | 4.8 | 93 | Citations (PDF) |
| 203 | Comparative Flavivirus-Host Protein Interaction Mapping Reveals Mechanisms of Dengue and Zika Virus PathogenesisCell, 2018, 175, 1931-1945.e18 | 23.4 | 369 | Citations (PDF) |
| 204 | ISRE-Reporter Mouse Reveals High Basal and Induced Type I IFN Responses in Inflammatory Monocytes | 4.4 | 75 | Citations (PDF) |
| 205 | Structural–functional interactions of NS1-BP protein with the splicing and mRNA export machineries for viral and host gene expression | 5.2 | 36 | Citations (PDF) |
| 206 | Influenza Virus NS1 Protein-RNA Interactome Reveals Intron Targeting | 2.4 | 34 | Citations (PDF) |
| 207 | A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies | 1.9 | 20 | Citations (PDF) |
| 208 | Influenza virus infection causes global RNAPII termination defects | 5.8 | 61 | Citations (PDF) |
| 209 | Novel triple-reassortant influenza viruses in pigs, Guangxi, China | 3.9 | 41 | Citations (PDF) |
| 210 | A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats | 2.0 | 17 | Citations (PDF) |
| 211 | Influenza | 37.8 | 1,537 | Citations (PDF) |
| 212 | Innate immune sensor LGP2 is cleaved by the Leader protease of foot-and-mouth disease virus | 2.9 | 39 | Citations (PDF) |
| 213 | An Immunocompetent Mouse Model of Zika Virus Infection | 12.2 | 238 | Citations (PDF) |
| 214 | Transcriptome Analysis of Infected and Bystander Type 2 Alveolar Epithelial Cells during Influenza A Virus Infection Reveals
In Vivo
Wnt Pathway Downregulation | 2.4 | 62 | Citations (PDF) |
| 215 | Transcription Elongation Can Affect Genome 3D StructureCell, 2018, 174, 1522-1536.e22 | 23.4 | 485 | Citations (PDF) |
| 216 | Emergence and Evolution of Novel Reassortant Influenza A Viruses in Canines in Southern China | 3.1 | 64 | Citations (PDF) |
| 217 | Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry | 6.5 | 159 | Citations (PDF) |
| 218 | Co-regulatory activity of hnRNP K and NS1-BP in influenza and human mRNA splicing | 10.8 | 84 | Citations (PDF) |
| 219 | MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection | 2.9 | 122 | Citations (PDF) |
| 220 | Influenza virus exploits tunneling nanotubes for cell-to-cell spread | 2.7 | 151 | Citations (PDF) |
| 221 | Systems-based analysis of RIG-I-dependent signalling identifies KHSRP as an inhibitor of RIG-I receptor activation | 9.9 | 36 | Citations (PDF) |
| 222 | Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins | 14.1 | 179 | Citations (PDF) |
| 223 | Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection | 3.1 | 53 | Citations (PDF) |
| 224 | Inactivated influenza virus vaccines: the future of TIV and QIV | 3.2 | 34 | Citations (PDF) |
| 225 | The RNA Exosome Syncs IAV-RNAPII Transcription to Promote Viral Ribogenesis and InfectivityCell, 2017, 169, 679-692.e14 | 23.4 | 58 | Citations (PDF) |
| 226 | Antagonism of type I interferon by flaviviruses | 1.5 | 85 | Citations (PDF) |
| 227 | Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model | 2.4 | 36 | Citations (PDF) |
| 228 | Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection | 9.9 | 378 | Citations (PDF) |
| 229 | Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion | 3.1 | 87 | Citations (PDF) |
| 230 | Constitutive resistance to viral infection in human CD141
+
dendritic cells | 8.9 | 115 | Citations (PDF) |
| 231 | A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies | 3.9 | 141 | Citations (PDF) |
| 232 | Ten Strategies of Interferon Evasion by Viruses | 12.2 | 440 | Citations (PDF) |
| 233 | Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus | 3.9 | 32 | Citations (PDF) |
| 234 | Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death | 10.8 | 56 | Citations (PDF) |
| 235 | Single-cell analysis of early antiviral gene expression reveals a determinant of stochastic
IFNB1
expression | 1.4 | 27 | Citations (PDF) |
| 236 | Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes | 2.4 | 87 | Citations (PDF) |
| 237 | Synergistic drug combination effectively blocks Ebola virus infection | 2.7 | 88 | Citations (PDF) |
| 238 | TRIM25 in the Regulation of the Antiviral Innate Immunity | 3.3 | 151 | Citations (PDF) |
| 239 | Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication | 2.9 | 103 | Citations (PDF) |
| 240 | Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA | 1.9 | 32 | Citations (PDF) |
| 241 | Human interactome of the influenza B virus NS1 protein | 1.9 | 24 | Citations (PDF) |
| 242 | A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses | 2.9 | 226 | Citations (PDF) |
| 243 | Infection in Health Personnel with High and Low Levels of Exposure in a Hospital Setting during the H1N1 2009 Influenza A Pandemic | 1.5 | 12 | Citations (PDF) |
| 244 | Antiviral Role of IFITM Proteins in African Swine Fever Virus Infection | 1.5 | 67 | Citations (PDF) |
| 245 | Structure of the NS3 helicase from Zika virus | 5.8 | 97 | Citations (PDF) |
| 246 | Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection | 2.4 | 37 | Citations (PDF) |
| 247 | ISG15 deficiency and increased viral resistance in humans but not mice | 10.8 | 207 | Citations (PDF) |
| 248 | A High-Resolution Look at Influenza Virus Antigenic Drift | 2.2 | 3 | Citations (PDF) |
| 249 | Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling | 12.2 | 768 | Citations (PDF) |
| 250 | Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge | 2.0 | 31 | Citations (PDF) |
| 251 | Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation | 26.1 | 168 | Citations (PDF) |
| 252 | ICOS+PD-1+CXCR3+ T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination | 2.7 | 178 | Citations (PDF) |
| 253 | The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells | 5.9 | 83 | Citations (PDF) |
| 254 | Influenza virus mRNA trafficking through host nuclear speckles | 9.9 | 114 | Citations (PDF) |
| 255 | Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism | 5.2 | 55 | Citations (PDF) |
| 256 | A conserved influenza A virus nucleoprotein code controls specific viral genome packaging | 10.8 | 44 | Citations (PDF) |
| 257 | Macroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD8+ T Cell Responses | 4.4 | 165 | Citations (PDF) |
| 258 | Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection | 16.6 | 145 | Citations (PDF) |
| 259 | Antiviral innate immunity through the lens of systems biology | 2.0 | 12 | Citations (PDF) |
| 260 | La Piedad Michoacán Mexico Virus V protein antagonizes type I interferon response by binding STAT2 protein and preventing STATs nuclear translocation | 2.0 | 8 | Citations (PDF) |
| 261 | Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine | 2.0 | 8 | Citations (PDF) |
| 262 | H7N9 influenza virus neutralizing antibodies that possess few somatic mutations | 6.6 | 76 | Citations (PDF) |
| 263 | PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1Cell, 2015, 161, 1293-1305 | 23.4 | 202 | Citations (PDF) |
| 264 | Meta- and Orthogonal Integration of Influenza “OMICs” Data Defines a Role for UBR4 in Virus Budding | 12.2 | 937 | Citations (PDF) |
| 265 | A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein | 2.7 | 29 | Citations (PDF) |
| 266 | The Nucleoprotein of Newly Emerged H7N9 Influenza A Virus Harbors a Unique Motif Conferring Resistance to Antiviral Human MxA | 2.4 | 72 | Citations (PDF) |
| 267 | RNase L Targets Distinct Sites in Influenza A Virus RNAs | 2.4 | 62 | Citations (PDF) |
| 268 | Influenza Virus Adaptation PB2-627K Modulates Nucleocapsid Inhibition by the Pathogen Sensor RIG-I | 12.2 | 141 | Citations (PDF) |
| 269 | A Newly Emerged Swine-Origin Influenza A(H3N2) Variant Dampens Host Antiviral Immunity but Induces Potent Inflammasome Activation | 2.2 | 6 | Citations (PDF) |
| 270 | The therapeutic effect of death: Newcastle disease virus and its antitumor potential | 2.0 | 47 | Citations (PDF) |
| 271 | Interference of viral effector proteins with chromatin, transcription, and the epigenome | 4.9 | 17 | Citations (PDF) |
| 272 | Human Dendritic Cell Response Signatures Distinguish 1918, Pandemic, and Seasonal H1N1 Influenza Viruses | 2.4 | 30 | Citations (PDF) |
| 273 | HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3 | 2.4 | 32 | Citations (PDF) |
| 274 | Against the clock towards new Ebola virus therapies | 2.0 | 14 | Citations (PDF) |
| 275 | Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains | 4.8 | 3 | Citations (PDF) |
| 276 | Enhancement of the Proapoptotic Properties of Newcastle Disease Virus Promotes Tumor Remission in Syngeneic Murine Cancer Models | 1.2 | 28 | Citations (PDF) |
| 277 | RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus | 2.4 | 42 | Citations (PDF) |
| 278 | Interactive Big Data Resource to Elucidate Human Immune Pathways and Diseases | 16.6 | 52 | Citations (PDF) |
| 279 | Distinct Patterns of B-Cell Activation and Priming by Natural Influenza Virus Infection Versus Inactivated Influenza Vaccination | 2.2 | 27 | Citations (PDF) |
| 280 | Mapping of the interaction domains of the Crimean–Congo hemorrhagic fever virus nucleocapsid protein | 1.9 | 18 | Citations (PDF) |
| 281 | Prothymosin α Variants Isolated From CD8+ T Cells and Cervicovaginal Fluid Suppress HIV-1 Replication Through Type I Interferon Induction | 2.2 | 13 | Citations (PDF) |
| 282 | In memoriam – Richard M. Elliott (1954–2015) | 1.9 | 4 | Citations (PDF) |
| 283 | Preexisting human antibodies neutralize recently emerged H7N9 influenza strains | 6.6 | 129 | Citations (PDF) |
| 284 | Expected and Unexpected Features of the Newly Discovered Bat Influenza A-like Viruses | 2.9 | 43 | Citations (PDF) |
| 285 | STAT2 signaling and dengue virus infection | 0.0 | 23 | Citations (PDF) |
| 286 | 17β-Estradiol Protects Primary Macrophages Against HIV Infection Through Induction of Interferon-Alpha | 0.9 | 38 | Citations (PDF) |
| 287 | Divergent H7 Immunogens Offer Protection from H7N9 Virus Challenge | 2.4 | 53 | Citations (PDF) |
| 288 | Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs | 3.9 | 213 | Citations (PDF) |
| 289 | Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response | 2.9 | 76 | Citations (PDF) |
| 290 | In Vivo Ligands of MDA5 and RIG-I in Measles Virus-Infected Cells | 2.9 | 133 | Citations (PDF) |
| 291 | Influenza Vaccines: A Moving Interdisciplinary Field | 2.2 | 24 | Citations (PDF) |
| 292 | North American Triple Reassortant and Eurasian H1N1 Swine Influenza Viruses Do Not Readily Reassort to Generate a 2009 Pandemic H1N1-Like Virus | 3.1 | 17 | Citations (PDF) |
| 293 | RIG-I Detects mRNA of Intracellular Salmonella enterica Serovar Typhimurium during Bacterial Infection | 3.1 | 59 | Citations (PDF) |
| 294 | A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β-amyloid antibody responses in mice with pre-existing virus specific memory | 1.7 | 4 | Citations (PDF) |
| 295 | Turkey Versus Guinea Pig Red Blood Cells: Hemagglutination Differences Alter Hemagglutination Inhibition Responses Against Influenza A/H1N1 | 0.9 | 27 | Citations (PDF) |
| 296 | Tumor Suppressor Cylindromatosis (CYLD) Controls HIV Transcription in an NF-κB-Dependent Manner | 2.4 | 27 | Citations (PDF) |
| 297 | Immunologic Characterization of a Rhesus Macaque H1N1 Challenge Model for Candidate Influenza Virus Vaccine Assessment | 3.1 | 29 | Citations (PDF) |
| 298 | The origin of the PB1 segment of swine influenza A virus subtype H1N2 determines viral pathogenicity in mice | 2.0 | 7 | Citations (PDF) |
| 299 | Differences in Antibody Responses Between Trivalent Inactivated Influenza Vaccine and Live Attenuated Influenza Vaccine Correlate With the Kinetics and Magnitude of Interferon Signaling in Children | 2.2 | 85 | Citations (PDF) |
| 300 | Hijacking of RIG-I Signaling Proteins into Virus-Induced Cytoplasmic Structures Correlates with the Inhibition of Type I Interferon Responses | 2.4 | 125 | Citations (PDF) |
| 301 | Model of influenza A virus infection: Dynamics of viral antagonism and innate immune response | 1.1 | 18 | Citations (PDF) |
| 302 | TRIMmunity: The Roles of the TRIM E3-Ubiquitin Ligase Family in Innate Antiviral Immunity | 2.9 | 355 | Citations (PDF) |
| 303 | Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host | 12.2 | 244 | Citations (PDF) |
| 304 | Activation and regulation of pathogen sensor RIG-I | 7.3 | 49 | Citations (PDF) |
| 305 | InTRIMsic immunity: Positive and negative regulation of immune signaling by tripartite motif proteins | 7.3 | 140 | Citations (PDF) |
| 306 | Mutations to PB2 and NP Proteins of an Avian Influenza Virus Combine To Confer Efficient Growth in Primary Human Respiratory Cells | 2.4 | 39 | Citations (PDF) |
| 307 | An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus | 10.8 | 89 | Citations (PDF) |
| 308 | Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets | 2.4 | 133 | Citations (PDF) |
| 309 | Human Responses to Influenza Vaccination Show Seroconversion Signatures and Convergent Antibody Rearrangements | 12.2 | 273 | Citations (PDF) |
| 310 | Distinct Cross-reactive B-Cell Responses to Live Attenuated and Inactivated Influenza Vaccines | 2.2 | 28 | Citations (PDF) |
| 311 | The Interferon Signaling Antagonist Function of Yellow Fever Virus NS5 Protein Is Activated by Type I Interferon | 12.2 | 162 | Citations (PDF) |
| 312 | Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans | 5.2 | 246 | Citations (PDF) |
| 313 | Negative regulation of NF-κB activity by brain-specific TRIpartite Motif protein 9 | 10.8 | 81 | Citations (PDF) |
| 314 | mTOR/p70S6K signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during influenza A infection | 1.6 | 63 | Citations (PDF) |
| 315 | One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge | 2.0 | 60 | Citations (PDF) |
| 316 | Unanchored K48-Linked Polyubiquitin Synthesized by the E3-Ubiquitin Ligase TRIM6 Stimulates the Interferon-IKKε Kinase-Mediated Antiviral Response | 16.6 | 178 | Citations (PDF) |
| 317 | Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation | 30.6 | 554 | Citations (PDF) |
| 318 | Effect of Cholecalciferol Supplementation on Inflammation and Cellular Alloimmunity in Hemodialysis Patients: Data from a Randomized Controlled Pilot Trial | 1.5 | 15 | Citations (PDF) |
| 319 | IGHV4-34 B-Cell Receptor Immunoglobulins from CLL Stereotyped Subset 4 React with Influenza A Virus: Requirement for IGHV-D-J/Iglv-J Rearrangement and Isotype Switching to IgGBlood, 2014, 124, 299-299 | 3.6 | 1 | Citations (PDF) |
| 320 | Transmission studies resume for avian flu | 30.6 | 20 | Citations (PDF) |
| 321 | MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies | 19.7 | 84 | Citations (PDF) |
| 322 | Accumulation of CD11b+Gr-1+ cells in the lung, blood and bone marrow of mice infected with highly pathogenic H5N1 and H1N1 influenza viruses | 1.1 | 18 | Citations (PDF) |
| 323 | Type I Interferon Imposes a TSG101/ISG15 Checkpoint at the Golgi for Glycoprotein Trafficking during Influenza Virus Infection | 12.2 | 53 | Citations (PDF) |
| 324 | Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses | 2.4 | 195 | Citations (PDF) |
| 325 | Evolution of the Hemagglutinin Protein of the New Pandemic H1N1 Influenza Virus: Maintaining Optimal Receptor Binding by Compensatory Substitutions | 2.4 | 45 | Citations (PDF) |
| 326 | Incoming RNA Virus Nucleocapsids Containing a 5′-Triphosphorylated Genome Activate RIG-I and Antiviral Signaling | 12.2 | 172 | Citations (PDF) |
| 327 | Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways | 7.0 | 64 | Citations (PDF) |
| 328 | The E3-Ligase TRIM Family of Proteins Regulates Signaling Pathways Triggered by Innate Immune Pattern-Recognition Receptors | 16.6 | 317 | Citations (PDF) |
| 329 | H3N2 Influenza Virus Infection Induces Broadly Reactive Hemagglutinin Stalk Antibodies in Humans and Mice | 2.4 | 156 | Citations (PDF) |
| 330 | Tissue-Resident Macrophages Self-Maintain Locally throughout Adult Life with Minimal Contribution from Circulating Monocytes | 16.6 | 2,157 | Citations (PDF) |
| 331 | Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses | 8.7 | 124 | Citations (PDF) |
| 332 | Insertion of a GFP Reporter Gene in Influenza Virus | 0.0 | 62 | Citations (PDF) |
| 333 | Cellular RNA Binding Proteins NS1-BP and hnRNP K Regulate Influenza A Virus RNA Splicing | 2.9 | 97 | Citations (PDF) |
| 334 | Novel vaccine strategies against emerging viruses | 3.2 | 34 | Citations (PDF) |
| 335 | Dengue Virus Co-opts UBR4 to Degrade STAT2 and Antagonize Type I Interferon Signaling | 2.9 | 230 | Citations (PDF) |
| 336 | ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection | 2.9 | 41 | Citations (PDF) |
| 337 | Recombinant IgA Is Sufficient To Prevent Influenza Virus Transmission in Guinea Pigs | 2.4 | 88 | Citations (PDF) |
| 338 | Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility | 10.8 | 156 | Citations (PDF) |
| 339 | A Sendai Virus-Derived RNA Agonist of RIG-I as a Virus Vaccine Adjuvant | 2.4 | 123 | Citations (PDF) |
| 340 | Protection against Lethal Influenza with a Viral Mimic | 2.4 | 68 | Citations (PDF) |
| 341 | Contribution of Double-Stranded RNA and CPSF30 Binding Domains of Influenza Virus NS1 to the Inhibition of Type I Interferon Production and Activation of Human Dendritic Cells | 2.4 | 33 | Citations (PDF) |
| 342 | H7N9 influenza viruses interact preferentially with α2,3-linked sialic acids and bind weakly to α2,6-linked sialic acids | 1.9 | 73 | Citations (PDF) |
| 343 | Induction of ICOS
+
CXCR3
+
CXCR5
+
T
H
Cells Correlates with Antibody Responses to Influenza Vaccination | 8.7 | 619 | Citations (PDF) |
| 344 | Overcoming NS1-Mediated Immune Antagonism Involves Both Interferon-Dependent and Independent Mechanisms | 1.0 | 6 | Citations (PDF) |
| 345 | Influenza A(H1N1)pdm09 virus infection in marine mammals in California | 3.9 | 16 | Citations (PDF) |
| 346 | Genetic Requirement for Hemagglutinin Glycosylation and Its Implications for Influenza A H1N1 Virus Evolution | 2.4 | 49 | Citations (PDF) |
| 347 | ATPase‐driven oligomerization of RIG‐I on RNA allows optimal activation of type‐I interferon | 3.5 | 124 | Citations (PDF) |
| 348 | Rescue of Recombinant Newcastle Disease Virus from cDNA | 0.2 | 19 | Citations (PDF) |
| 349 | Pandemic H1N1 Influenza Isolated from Free-Ranging Northern Elephant Seals in 2010 off the Central California Coast | 1.5 | 60 | Citations (PDF) |
| 350 | Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses | 1.5 | 18 | Citations (PDF) |
| 351 | Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity | 30.6 | 907 | Citations (PDF) |
| 352 | Rescue of Recombinant Newcastle Disease Virus from cDNA | 0.2 | 0 | Citations (PDF) |
| 353 | Cytopathogenesis of Vesicular Stomatitis Virus Is Regulated by the PSAP Motif of M Protein in a Species-Dependent Manner | 2.2 | 9 | Citations (PDF) |
| 354 | Species-Specific Inhibition of RIG-I Ubiquitination and IFN Induction by the Influenza A Virus NS1 Protein | 2.9 | 306 | Citations (PDF) |
| 355 | Live Attenuated Influenza Vaccine Provides Superior Protection from Heterologous Infection in Pigs with Maternal Antibodies without Inducing Vaccine-Associated Enhanced Respiratory Disease | 2.4 | 123 | Citations (PDF) |
| 356 | Arterivirus and Nairovirus Ovarian Tumor Domain-Containing Deubiquitinases Target Activated RIG-I To Control Innate Immune Signaling | 2.4 | 120 | Citations (PDF) |
| 357 | Pause on avian flu transmission studies | 30.6 | 49 | Citations (PDF) |
| 358 | Influenza Virus Sequence Feature Variant Type Analysis: Evidence of a Role for NS1 in Influenza Virus Host Range Restriction | 2.4 | 36 | Citations (PDF) |
| 359 | Recombinant Influenza A Viruses with Enhanced Levels of PB1 and PA Viral Protein Expression | 2.4 | 16 | Citations (PDF) |
| 360 | Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses | 5.2 | 259 | Citations (PDF) |
| 361 | Strain-Specific Contribution of NS1-Activated Phosphoinositide 3-Kinase Signaling to Influenza A Virus Replication and Virulence | 2.4 | 40 | Citations (PDF) |
| 362 | Increased Viral Loads and Exacerbated Innate Host Responses in Aged Macaques Infected with the 2009 Pandemic H1N1 Influenza A Virus | 2.4 | 61 | Citations (PDF) |
| 363 | Attenuated Influenza Virus Construct with Enhanced Hemagglutinin Protein Expression | 2.4 | 17 | Citations (PDF) |
| 364 | Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses | 2.4 | 72 | Citations (PDF) |
| 365 | Residue Y161 of Influenza Virus Hemagglutinin Is Involved in Viral Recognition of Sialylated Complexes from Different Hosts | 2.4 | 25 | Citations (PDF) |
| 366 | Pathogenicity and transmissibility of reassortant H9 influenza viruses with genes from pandemic H1N1 virus | 1.9 | 38 | Citations (PDF) |
| 367 | Structure and Dynamics of the Second CARD of Human RIG-I Provide Mechanistic Insights into Regulation of RIG-I Activation | 2.4 | 46 | Citations (PDF) |
| 368 | HERC6 Is the Main E3 Ligase for Global ISG15 Conjugation in Mouse Cells | 1.5 | 115 | Citations (PDF) |
| 369 | Identification of Small Molecules with Type I Interferon Inducing Properties by High-Throughput Screening | 1.5 | 29 | Citations (PDF) |
| 370 | Suppression of the antiviral response by an influenza histone mimic | 30.6 | 307 | Citations (PDF) |
| 371 | The neuraminidase and matrix genes of the 2009 pandemic influenza H1N1 virus cooperate functionally to facilitate efficient replication and transmissibility in pigs | 1.9 | 37 | Citations (PDF) |
| 372 | Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses | 5.2 | 74 | Citations (PDF) |
| 373 | Influenza Research Database: an integrated bioinformatics resource for influenza research and surveillance | 2.2 | 284 | Citations (PDF) |
| 374 | Cross-presenting CD103+ dendritic cells are protected from influenza virus infection | 6.6 | 238 | Citations (PDF) |
| 375 | Host Modulators of H1N1 Cytopathogenicity | 1.5 | 33 | Citations (PDF) |
| 376 | Influenza-Infected Neutrophils within the Infected Lungs Act as Antigen Presenting Cells for Anti-Viral CD8+ T Cells | 1.5 | 118 | Citations (PDF) |
| 377 | Influenza A viruses: new research developments | 58.2 | 592 | Citations (PDF) |
| 378 | Induction and evasion of type I interferon responses by influenza viruses | 2.0 | 225 | Citations (PDF) |
| 379 | Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor | 9.1 | 73 | Citations (PDF) |
| 380 | Host-Range Restriction of Vaccinia Virus E3L Deletion Mutant Can Be Overcome In Vitro, but Not In Vivo, by Expression of the Influenza Virus NS1 Protein | 1.5 | 18 | Citations (PDF) |
| 381 | Development and Characterization of a Highly Specific and Sensitive SYBR Green Reverse Transcriptase PCR Assay for Detection of the 2009 Pandemic H1N1 Influenza Virus on the Basis of Sequence Signatures | 2.5 | 18 | Citations (PDF) |
| 382 | Major Histocompatibility Complex Class II Expression and Hemagglutinin Subtype Influence the Infectivity of Type A Influenza Virus for Respiratory Dendritic Cells | 2.4 | 21 | Citations (PDF) |
| 383 | Programming the magnitude and persistence of antibody responses with innate immunity | 30.6 | 950 | Citations (PDF) |
| 384 | The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease | 4.8 | 15 | Citations (PDF) |
| 385 | Host- and Strain-Specific Regulation of Influenza Virus Polymerase Activity by Interacting Cellular Proteins | 3.1 | 171 | Citations (PDF) |
| 386 | The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome pathways | 1.9 | 46 | Citations (PDF) |
| 387 | Virulence determinants of pandemic influenza viruses | 6.6 | 196 | Citations (PDF) |
| 388 | The M Segment of the 2009 New Pandemic H1N1 Influenza Virus Is Critical for Its High Transmission Efficiency in the Guinea Pig Model | 2.4 | 134 | Citations (PDF) |
| 389 | Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice | 2.4 | 45 | Citations (PDF) |
| 390 | Induction of Type I Interferon Secretion through Recombinant Newcastle Disease Virus Expressing Measles Virus Hemagglutinin Stimulates Antibody Secretion in the Presence of Maternal Antibodies | 2.4 | 20 | Citations (PDF) |
| 391 | The Early Interferon Response to Rotavirus Is Regulated by PKR and Depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3 | 2.4 | 134 | Citations (PDF) |
| 392 | A Reassortment-Incompetent Live Attenuated Influenza Virus Vaccine for Protection against Pandemic Virus Strains | 2.4 | 54 | Citations (PDF) |
| 393 | Maternal Influenza Viral Infection Causes Schizophrenia-Like Alterations of 5-HT
2A
and mGlu
2
Receptors in the Adult Offspring | 2.3 | 120 | Citations (PDF) |
| 394 | Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease | 5.2 | 103 | Citations (PDF) |
| 395 | An Enzymatic Assay for Detection of Viral Entry | 3.0 | 12 | Citations (PDF) |
| 396 | Differential Contribution of PB1-F2 to the Virulence of Highly Pathogenic H5N1 Influenza A Virus in Mammalian and Avian Species | 2.9 | 137 | Citations (PDF) |
| 397 | The Influenza Virus Protein PB1-F2 Inhibits the Induction of Type I Interferon at the Level of the MAVS Adaptor Protein | 2.9 | 222 | Citations (PDF) |
| 398 | A Transient Homotypic Interaction Model for the Influenza A Virus NS1 Protein Effector Domain | 1.5 | 55 | Citations (PDF) |
| 399 | Dissection of the Influenza A Virus Endocytic Routes Reveals Macropinocytosis as an Alternative Entry Pathway | 2.9 | 320 | Citations (PDF) |
| 400 | Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus | 1.1 | 31 | Citations (PDF) |
| 401 | An enzymatic virus-like particle assay for sensitive detection of virus entry | 1.0 | 67 | Citations (PDF) |
| 402 | Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection | 1.9 | 6 | Citations (PDF) |
| 403 | Regulation of PURA gene transcription by three promoters generating distinctly spliced 5-prime leaders: a novel means of fine control over tissue specificity and viral signals | 4.0 | 11 | Citations (PDF) |
| 404 | Evasion of innate and adaptive immune responses by influenza A virus | 0.7 | 94 | Citations (PDF) |
| 405 | Complete-Proteome Mapping of Human Influenza A Adaptive Mutations: Implications for Human Transmissibility of Zoonotic Strains | 1.5 | 87 | Citations (PDF) |
| 406 | Generation of Recombinant Influenza Virus from Plasmid DNA | 0.2 | 121 | Citations (PDF) |
| 407 | Virulence-Associated Substitution D222G in the Hemagglutinin of 2009 Pandemic Influenza A(H1N1) Virus Affects Receptor Binding | 2.4 | 211 | Citations (PDF) |
| 408 | Engineered RNA viral synthesis of microRNAs | 5.2 | 90 | Citations (PDF) |
| 409 | Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain | 3.1 | 496 | Citations (PDF) |
| 410 | Negative Role of RIG-I Serine 8 Phosphorylation in the Regulation of Interferon-β Production | 1.3 | 101 | Citations (PDF) |
| 411 | Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing | 5.2 | 407 | Citations (PDF) |
| 412 | Inhibition of the Ubiquitin-Proteasome System Affects Influenza A Virus Infection at a Postfusion Step | 2.4 | 88 | Citations (PDF) |
| 413 | Oseltamivir-Resistant Variants of the 2009 Pandemic H1N1 Influenza A Virus Are Not Attenuated in the Guinea Pig and Ferret Transmission Models | 2.4 | 95 | Citations (PDF) |
| 414 | Transcription Factor Redundancy Ensures Induction of the Antiviral State | 1.3 | 116 | Citations (PDF) |
| 415 | Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus | 5.2 | 411 | Citations (PDF) |
| 416 | Variations in the Hemagglutinin of the 2009 H1N1 Pandemic Virus: Potential for Strains with Altered Virulence Phenotype? | 2.9 | 113 | Citations (PDF) |
| 417 | Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines | 2.9 | 179 | Citations (PDF) |
| 418 | NF-κB RelA Subunit Is Crucial for Early IFN-β Expression and Resistance to RNA Virus Replication | 0.8 | 139 | Citations (PDF) |
| 419 | Inefficient Control of Host Gene Expression by the 2009 Pandemic H1N1 Influenza A Virus NS1 Protein | 2.4 | 166 | Citations (PDF) |
| 420 | Phosphorylation-Mediated Negative Regulation of RIG-I Antiviral Activity | 2.4 | 124 | Citations (PDF) |
| 421 | Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus | 10.8 | 63 | Citations (PDF) |
| 422 | Innate Immune Evasion Strategies of Influenza Viruses | 1.4 | 172 | Citations (PDF) |
| 423 | 5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication | 2.2 | 31 | Citations (PDF) |
| 424 | Viral tricks to grid-lock the type I interferon system | 4.9 | 235 | Citations (PDF) |
| 425 | Mouse STAT2 Restricts Early Dengue Virus Replication | 12.2 | 182 | Citations (PDF) |
| 426 | NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets | 2.0 | 48 | Citations (PDF) |
| 427 | Influenza A virus-generated small RNAs regulate the switch from transcription to replication | 5.2 | 208 | Citations (PDF) |
| 428 | Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes | 5.2 | 292 | Citations (PDF) |
| 429 | Generation of Recombinant Influenza Virus from Plasmid DNA | 0.2 | 6 | Citations (PDF) |
| 430 | Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air | 5.2 | 213 | Citations (PDF) |
| 431 | Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus | 5.2 | 342 | Citations (PDF) |
| 432 | Hantaan Virus Nucleocapsid Protein Binds to Importin α Proteins and Inhibits Tumor Necrosis Factor Alpha-Induced Activation of Nuclear Factor Kappa B | 2.4 | 96 | Citations (PDF) |
| 433 | The NS1 Protein of a Human Influenza Virus Inhibits Type I Interferon Production and the Induction of Antiviral Responses in Primary Human Dendritic and Respiratory Epithelial Cells | 2.4 | 109 | Citations (PDF) |
| 434 | Identification of Amino Acid Residues Critical for the Anti-Interferon Activity of the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus | 2.4 | 128 | Citations (PDF) |
| 435 | Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza | 2.4 | 245 | Citations (PDF) |
| 436 | Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses | 6.0 | 88 | Citations (PDF) |
| 437 | Influenza B Virus Ribonucleoprotein Is a Potent Activator of the Antiviral Kinase PKR | 2.9 | 46 | Citations (PDF) |
| 438 | Transmission of Influenza Virus via Aerosols and Fomites in the Guinea Pig Model | 2.2 | 189 | Citations (PDF) |
| 439 | NS5 of Dengue Virus Mediates STAT2 Binding and Degradation | 2.4 | 420 | Citations (PDF) |
| 440 | Optimization of Human Immunodeficiency Virus Gag Expression by Newcastle Disease Virus Vectors for the Induction of Potent Immune Responses | 2.4 | 85 | Citations (PDF) |
| 441 | A novel high‐throughput cell‐based method for integrated quantification of type I interferons and in vitro screening of immunostimulatory RNA drug delivery | 2.7 | 17 | Citations (PDF) |
| 442 | Genetically engineered Newcastle disease virus for malignant melanoma therapy | 3.0 | 75 | Citations (PDF) |
| 443 | The functional impairment of natural killer cells during influenza virus infection | 2.0 | 66 | Citations (PDF) |
| 444 | Influenza A Virus NS1 Targets the Ubiquitin Ligase TRIM25 to Evade Recognition by the Host Viral RNA Sensor RIG-I | 12.2 | 843 | Citations (PDF) |
| 445 | Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with Lysosomes | 12.2 | 514 | Citations (PDF) |
| 446 | Induction of type I interferon by RNA viruses: cellular receptors and their substrates | 1.9 | 126 | Citations (PDF) |
| 447 | Human host factors required for influenza virus replication | 30.6 | 812 | Citations (PDF) |
| 448 | Recent strategies to identify broadly neutralizing antibodies against influenza A virus | 2.2 | 0 | Citations (PDF) |
| 449 | Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy | 6.0 | 86 | Citations (PDF) |
| 450 | A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus | 2.0 | 53 | Citations (PDF) |
| 451 | Heterologous HA DNA vaccine prime—inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses | 2.0 | 87 | Citations (PDF) |
| 452 | Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry | 2.0 | 72 | Citations (PDF) |
| 453 | rVSV(MΔ51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy | 2.3 | 73 | Citations (PDF) |
| 454 | Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity | 2.4 | 983 | Citations (PDF) |
| 455 | Influenza A Virus Strains Differ in Sensitivity to the Antiviral Action of Mx-GTPase | 2.4 | 140 | Citations (PDF) |
| 456 | BioHealthBase: informatics support in the elucidation of influenza virus host–pathogen interactions and virulence | 10.7 | 71 | Citations (PDF) |
| 457 | Influenza B Virus NS1-Truncated Mutants: Live-Attenuated Vaccine Approach | 2.4 | 121 | Citations (PDF) |
| 458 | Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus | 5.2 | 144 | Citations (PDF) |
| 459 | H5N1 and 1918 Pandemic Influenza Virus Infection Results in Early and Excessive Infiltration of Macrophages and Neutrophils in the Lungs of Mice | 2.9 | 587 | Citations (PDF) |
| 460 | Exponential Enhancement of Oncolytic Vesicular Stomatitis Virus Potency by Vector-mediated Suppression of Inflammatory Responses In Vivo | 6.0 | 77 | Citations (PDF) |
| 461 | Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccinesBlood, 2008, 112, 3671-3678 | 3.6 | 62 | Citations (PDF) |
| 462 | Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells | 3.7 | 70 | Citations (PDF) |
| 463 | Detection of Respiratory Viruses and Subtype Identification of Influenza A Viruses by GreeneChipResp Oligonucleotide Microarray | 2.5 | 98 | Citations (PDF) |
| 464 | Recombinant influenza virus vectors | 0.5 | 5 | Citations (PDF) |
| 465 | IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses | 5.2 | 515 | Citations (PDF) |
| 466 | α‐Defensin Inhibits Influenza Virus Replication by Cell‐Mediated Mechanism(s) | 2.2 | 149 | Citations (PDF) |
| 467 | Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene | 5.2 | 187 | Citations (PDF) |
| 468 | Inhibition of Retinoic Acid-Inducible Gene I-Mediated Induction of Beta Interferon by the NS1 Protein of Influenza A Virus | 2.4 | 546 | Citations (PDF) |
| 469 | Peptide-Mediated Interference with Influenza A Virus Polymerase | 2.4 | 127 | Citations (PDF) |
| 470 | Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein | 2.4 | 429 | Citations (PDF) |
| 471 | Identification of Cellular Interaction Partners of the Influenza Virus Ribonucleoprotein Complex and Polymerase Complex Using Proteomic-Based Approaches | 2.2 | 210 | Citations (PDF) |
| 472 | Functional Genomic and Serological Analysis of the Protective Immune Response Resulting from Vaccination of Macaques with an NS1-Truncated Influenza Virus | 2.4 | 82 | Citations (PDF) |
| 473 | Differential Inhibition of Type I Interferon Induction by Arenavirus Nucleoproteins | 2.4 | 189 | Citations (PDF) |
| 474 | Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine | 2.0 | 132 | Citations (PDF) |
| 475 | Ovarian Tumor Domain-Containing Viral Proteases Evade Ubiquitin- and ISG15-Dependent Innate Immune Responses | 12.2 | 340 | Citations (PDF) |
| 476 | Structure of IRF-3 Bound to the PRDIII-I Regulatory Element of the Human Interferon-β Enhancer | 8.6 | 104 | Citations (PDF) |
| 477 | Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells | 2.2 | 9 | Citations (PDF) |
| 478 | Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines | 3.0 | 56 | Citations (PDF) |
| 479 | A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis | 1.6 | 54 | Citations (PDF) |
| 480 | The intracellular sites of early replication and budding of SARS-coronavirus | 1.6 | 387 | Citations (PDF) |
| 481 | Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle disease | 5.2 | 223 | Citations (PDF) |
| 482 | Antiviral Response in Pandemic Influenza Viruses | 2.7 | 68 | Citations (PDF) |
| 483 | Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus | 30.6 | 532 | Citations (PDF) |
| 484 | Sequence analysis and receptor specificity of the hemagglutinin of a recent influenza H2N2 virus isolated from chicken in North America | 1.8 | 19 | Citations (PDF) |
| 485 | Characterization of a mitochondrial-targeting signal in the PB2 protein of influenza viruses | 1.6 | 58 | Citations (PDF) |
| 486 | Integrated Molecular Signature of Disease: Analysis of Influenza Virus-Infected Macaques through Functional Genomics and Proteomics | 2.4 | 117 | Citations (PDF) |
| 487 | Lessons Learned from Reconstructing the 1918 Influenza Pandemic | 2.2 | 35 | Citations (PDF) |
| 488 | Prostate Tumor Cells Infected with a Recombinant Influenza Virus Expressing a Truncated NS1 Protein Activate Cytolytic CD8
+
Cells To Recognize Noninfected Tumor Cells | 2.4 | 31 | Citations (PDF) |
| 489 | Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination | 5.2 | 77 | Citations (PDF) |
| 490 | The guinea pig as a transmission model for human influenza viruses | 5.2 | 348 | Citations (PDF) |
| 491 | An Unconventional NLS is Critical for the Nuclear Import of the Influenza A Virus Nucleoprotein and Ribonucleoprotein | 1.8 | 143 | Citations (PDF) |
| 492 | Thogoto virus ML protein suppresses IRF3 function | 1.6 | 62 | Citations (PDF) |
| 493 | Mapping of the RNA promoter of Newcastle disease virus | 1.6 | 20 | Citations (PDF) |
| 494 | A Novel Paramyxovirus? | 2.7 | 15 | Citations (PDF) |
| 495 | Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1 | 2.9 | 338 | Citations (PDF) |
| 496 | Cellular Localization and Antigenic Characterization of Crimean-Congo Hemorrhagic Fever Virus Glycoproteins | 2.4 | 158 | Citations (PDF) |
| 497 | The Morphology and Composition of Influenza A Virus Particles Are Not Affected by Low Levels of M1 and M2 Proteins in Infected Cells | 2.4 | 38 | Citations (PDF) |
| 498 | Delivery ofChlamydiavaccines | 3.7 | 16 | Citations (PDF) |
| 499 | A Single Amino Acid Substitution in 1918 Influenza Virus Hemagglutinin Changes Receptor Binding Specificity | 2.4 | 389 | Citations (PDF) |
| 500 | Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing | 5.2 | 391 | Citations (PDF) |
| 501 | Nipah Virus V and W Proteins Have a Common STAT1-Binding Domain yet Inhibit STAT1 Activation from the Cytoplasmic and Nuclear Compartments, Respectively | 2.4 | 249 | Citations (PDF) |
| 502 | The N- and C-Terminal Domains of the NS1 Protein of Influenza B Virus Can Independently Inhibit IRF-3 and Beta Interferon Promoter Activation | 2.4 | 87 | Citations (PDF) |
| 503 | Induction of Cellular Immune Responses to Simian Immunodeficiency Virus Gag by Two Recombinant Negative-Strand RNA Virus Vectors | 2.4 | 40 | Citations (PDF) |
| 504 | Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus | 5.2 | 180 | Citations (PDF) |
| 505 | Global Host Immune Response: Pathogenesis and Transcriptional Profiling of Type A Influenza Viruses Expressing the Hemagglutinin and Neuraminidase Genes from the 1918 Pandemic Virus | 2.4 | 163 | Citations (PDF) |
| 506 | Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge | 1.6 | 18 | Citations (PDF) |
| 507 | Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants | 2.8 | 63 | Citations (PDF) |
| 508 | Syncytia Induction Enhances the Oncolytic Potential of Vesicular Stomatitis Virus in Virotherapy for Cancer | 2.6 | 105 | Citations (PDF) |
| 509 | Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants | 2.0 | 25 | Citations (PDF) |
| 510 | The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 | 2.4 | 462 | Citations (PDF) |
| 511 | Type I Interferon Induction Pathway, but Not Released Interferon, Participates in the Maturation of Dendritic Cells Induced by Negative‐Strand RNA Viruses | 2.2 | 106 | Citations (PDF) |
| 512 | Newcastle Disease Virus V Protein Is a Determinant of Host Range Restriction | 2.4 | 227 | Citations (PDF) |
| 513 | Prime-Boost Immunization Schedules Based on Influenza Virus and Vaccinia Virus Vectors Potentiate Cellular Immune Responses against Human Immunodeficiency Virus Env Protein Systemically and in the Genitorectal Draining Lymph Nodes | 2.4 | 75 | Citations (PDF) |
| 514 | A Recombinant Influenza A Virus Expressing anRNA-Binding-Defective NS1 Protein Induces High Levels of BetaInterferon and Is Attenuated inMice | 2.4 | 268 | Citations (PDF) |
| 515 | Chimeric Influenza A Viruses with a Functional Influenza B Virus Neuraminidase or Hemagglutinin | 2.4 | 32 | Citations (PDF) |
| 516 | Induction of Protective Immunity against Malaria by Priming-Boosting Immunization with Recombinant Cold-Adapted Influenza and Modified Vaccinia Ankara Viruses Expressing a CD8
+
-T-Cell Epitope Derived from the Circumsporozoite Protein of
Plasmodium yoelii | 2.4 | 39 | Citations (PDF) |
| 517 | Recombinant Paramyxovirus Type 1-Avian Influenza-H7 Virus as a Vaccine for Protection of Chickens Against Influenza and Newcastle Disease | 0.5 | 82 | Citations (PDF) |
| 518 | Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent mice | 6.0 | 50 | Citations (PDF) |
| 519 | Activation of Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTLs) by Human Dendritic Cells Infected with an Attenuated Influenza A Virus Expressing a CTL Epitope Derived from the HER-2/neu Proto-Oncogene | 2.4 | 30 | Citations (PDF) |
| 520 | Threonine 157 of Influenza Virus PA Polymerase Subunit Modulates RNA Replication in Infectious Viruses | 2.4 | 58 | Citations (PDF) |
| 521 | PKR Is Not Required for Interferon-γInhibition of VSV Replication in Neurons | 0.9 | 13 | Citations (PDF) |
| 522 | Inhibition of interferon signaling by dengue virus | 5.2 | 597 | Citations (PDF) |
| 523 | Newcastle Disease Virus (NDV)-Based Assay Demonstrates Interferon-Antagonist Activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins | 2.4 | 365 | Citations (PDF) |
| 524 | The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors | 2.4 | 172 | Citations (PDF) |
| 525 | Apical Budding of a Recombinant Influenza A Virus Expressing a Hemagglutinin Protein with a Basolateral Localization Signal | 2.4 | 54 | Citations (PDF) |
| 526 | Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: The role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza | 5.2 | 354 | Citations (PDF) |
| 527 | Functional Replacement of the Carboxy-Terminal Two-Thirds of the Influenza A Virus NS1 Protein with Short Heterologous Dimerization Domains | 2.4 | 97 | Citations (PDF) |
| 528 | Effects of Influenza A Virus NS1 Protein on Protein Expression: the NS1 Protein Enhances Translation and Is Not Required for Shutoff of Host Protein Synthesis | 2.4 | 107 | Citations (PDF) |
| 529 | Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus | 5.2 | 131 | Citations (PDF) |
| 530 | VIRUSES AND THE TYPE I INTERFERON ANTIVIRAL SYSTEM: INDUCTION AND EVASION | 2.7 | 122 | Citations (PDF) |
| 531 | Influenza virus still surprises | 4.9 | 49 | Citations (PDF) |
| 532 | Mechanisms of inhibition of the host interferon α/β-mediated antiviral responses by viruses | 1.7 | 115 | Citations (PDF) |
| 533 | Induction of immunological memory in baboons primed with DNA vaccine as neonates | 2.0 | 13 | Citations (PDF) |
| 534 | The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion | 7.3 | 397 | Citations (PDF) |
| 535 | Recombinant Newcastle Disease Virus as a Vaccine Vector | 2.4 | 229 | Citations (PDF) |
| 536 | Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes | 5.2 | 281 | Citations (PDF) |
| 537 | Plasmid-only rescue of influenza A virus vaccine candidates | 2.6 | 95 | Citations (PDF) |
| 538 | Inhibition of Interferon-Mediated Antiviral Responses by Influenza A Viruses and Other Negative-Strand RNA Viruses | 1.6 | 308 | Citations (PDF) |
| 539 | Title is missing! | 1.8 | 3 | Citations (PDF) |
| 540 | Influenza B and C Virus NEP (NS2) Proteins Possess Nuclear Export Activities | 2.4 | 67 | Citations (PDF) |
| 541 | IRF3 and IRF7 Phosphorylation in Virus-infected Cells Does Not Require Double-stranded RNA-dependent Protein Kinase R or IκB Kinase but Is Blocked by Vaccinia Virus E3L Protein | 1.3 | 212 | Citations (PDF) |
| 542 | Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach | 5.2 | 307 | Citations (PDF) |
| 543 | Influenza Virus NS1 Protein Counteracts PKR-Mediated Inhibition of Replication | 2.4 | 335 | Citations (PDF) |
| 544 | Transfectant influenza viruses as antigen delivery vectors | 3.9 | 13 | Citations (PDF) |
| 545 | Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon | 2.4 | 519 | Citations (PDF) |
| 546 | Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein | 2.4 | 544 | Citations (PDF) |
| 547 | The Ebola virus VP35 protein functions as a type I IFN antagonist | 5.2 | 470 | Citations (PDF) |
| 548 | 10.1016/s9999-9919(14)00144-9 | 0.0 | 0 | Citations (PDF) |
| 549 | Rescue of Influenza A Virus from Recombinant DNA | 2.4 | 787 | Citations (PDF) |
| 550 | Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants | 2.0 | 45 | Citations (PDF) |
| 551 | Mutation of Neuraminidase Cysteine Residues Yields Temperature-Sensitive Influenza Viruses | 2.4 | 18 | Citations (PDF) |
| 552 | Influenza A Virus RNA Polymerase Has the Ability To Stutter at the Polyadenylation Site of a Viral RNA Template during RNA Replication | 2.4 | 46 | Citations (PDF) |
| 553 | Transfectant Influenza A Viruses Are Effective Recombinant Immunogens in the Treatment of Experimental Cancer | 1.6 | 29 | Citations (PDF) |
| 554 | Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems | 1.6 | 976 | Citations (PDF) |
| 555 | Negative-strand RNA viruses: applications to biotechnology | 6.6 | 43 | Citations (PDF) |
| 556 | Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice | 5.2 | 83 | Citations (PDF) |
| 557 | Attenuation of Influenza A Virus mRNA Levels by Promoter Mutations | 2.4 | 55 | Citations (PDF) |
| 558 | Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene | 2.0 | 65 | Citations (PDF) |
| 559 | Development of Novel Influenza Virus Vaccines and Vectors | 2.2 | 40 | Citations (PDF) |
| 560 | Negative-strand RNA viruses: genetic engineering and applications. | 5.2 | 130 | Citations (PDF) |
| 561 | Characterization ofin VivoPrimary and Secondary CD8+T Cell Responses Induced by Recombinant Influenza and Vaccinia Viruses | 1.5 | 97 | Citations (PDF) |
| 562 | Nonconserved Nucleotides at the 3′ and 5′ Ends of an Influenza A Virus RNA Play an Important Role in Viral RNA Replication | 1.6 | 96 | Citations (PDF) |
| 563 | DNA Immunization of Newborn Mice with a Plasmid-Expressing Nucleoprotein of Influenza Virus | 0.9 | 64 | Citations (PDF) |
| 564 | Influenza Virus Vectors | 1.2 | 37 | Citations (PDF) |
| 565 | The cytoplasmic tail of the neuraminidase protein of influenza A virus does not play an important role in the packaging of this protein into viral envelopes | 2.0 | 56 | Citations (PDF) |
| 566 | Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus | 2.4 | 69 | Citations (PDF) |
| 567 | Expression of a foreign protein by influenza A virus | 2.4 | 96 | Citations (PDF) |
| 568 | Genetic Manipulation of Negative-Strand RNA Virus Genomes | 6.5 | 88 | Citations (PDF) |
| 569 | Enzymatic Glycosidase Activities in Experimental Obesity | 1.0 | 3 | Citations (PDF) |
| 570 | Increased influenza A virus sialidase activity with N-acetyl-9-O-acetylneuraminic acid-containing substrates resulting from influenza C virus O-acetylesterase action | 2.0 | 20 | Citations (PDF) |
| 571 | Increased serum N-acetyl-?-d-glucosaminidase and ?-ddd-mannosidase activities in obese subjects | 0.4 | 9 | Citations (PDF) |
| 572 | Transfection-mediated recombination of influenza A virus | 2.4 | 42 | Citations (PDF) |
| 573 | Mechanism of attenuation of a chimeric influenza A/B transfectant virus | 2.4 | 39 | Citations (PDF) |
| 574 | Protein-Protein Interactions in Membranes: A Simple Practical Laboratory Class for Advanced Students of Biochemistry and Molecular Biology | 0.1 | 3 | Citations (PDF) |
| 575 | Proteins of newcastle disease virus envelope: interaction between the outer hemagglutinin-neuraminidase glycoprotein and the inner non-glycosylated matrix protein | 2.5 | 30 | Citations (PDF) |
| 576 | Comparison of biological and physical properties of human and animal A(H1N1) influenza viruses | 1.0 | 12 | Citations (PDF) |
| 577 | Origins of the 2009 H1N1 influenza pandemic in swine in Mexico | 1.0 | 321 | Citations (PDF) |
| 578 | Three-stranded antiviral attack | 1.0 | 4 | Citations (PDF) |
| 579 | ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA | 1.0 | 88 | Citations (PDF) |
| 580 | Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment 0, , | | 1 | Citations (PDF) |
| 581 | Bioluminescent reporter influenza A viruses to track viral infections | 2.3 | 3 | Citations (PDF) |
| 582 | One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escape | 3.5 | 4 | Citations (PDF) |
| 583 | Immunogenicity and efficacy of a rabies-based vaccine against highly pathogenic influenza H5N1 virus | 3.9 | 0 | Citations (PDF) |
| 584 | Cross-reactivity between antibodies induced by European swine influenza vaccines and Spanish swine influenza strains | 1.6 | 0 | Citations (PDF) |
| 585 | Prenatal and postnatal effects of gestational immune activation on synaptic and neurodevelopmental pathways via epigenetic mechanisms | 3.9 | 0 | Citations (PDF) |
| 586 | MHC class II functions as a host-specific entry receptor for representative human and swine H3N2 influenza A viruses | 10.8 | 4 | Citations (PDF) |
| 587 | Longitudinal Surveillance of Influenza A Virus Exposure in Wild Boars (
Sus scrofa
) in Spain (2015–2023): Serologic and Virologic Evidence of Subtype Infections and
H5N1
Spillover Risk | 1.5 | 2 | Citations (PDF) |
| 588 | Abstract 4365: Pre-existing immunity boosts therapeutic efficacy of oncolytic influenza a virus in the presence and absence of neutralizing antibodies | 2.6 | 0 | Citations (PDF) |
| 589 | Abstract 4917: Establishment of patient-derived lung epithelial progenitor lines as a foundation for autologous immune and tumor modeling | 2.6 | 0 | Citations (PDF) |
| 590 | Fatal H5N1 Avian Influenza Pneumonia Associated with Autoantibodies Neutralizing Type I Interferons 0, 2, | | 0 | Citations (PDF) |
| 591 | C19-06 Targeting The Arih2-bik Axis: A Host-directed Therapeutic Strategy Against Influenza A Virus | 5.0 | 0 | Citations (PDF) |
| 592 | A potential RNA–RNA distal interaction competing with a functional pseudoknot in the 3′-untranslated region of SARS-like coronaviruses | 10.7 | 0 | Citations (PDF) |
| 593 | Reconstitution of human bronchial epithelial cells in humanized mice with autologous immune system 2335217 | 0.8 | 0 | Citations (PDF) |
